IT-901 is an orally active and potent NF-kappaB subunit c-Rel inhibitor with an IC50 of 0.1 µM, 3 µM for NF-kappaB DNA binding and c-Rel DNA binding, respectively. IT-901, a bioactive naphthalenethiobarbiturate derivative, has the potential for human lymphoid tumors and ameliorate graft-versus-host disease (GVHD)[1][2].
Molekulargewicht:
342.37
Reinheit:
99.32
CAS Nummer:
[1584121-99-2]
Formel:
C17H14N2O4S
Target-Kategorie:
NF-kappaB
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten